Bill Summary: The Biomarker Testing Coverage bills (S154/H136) would require health insurance plans to cover comprehensive biomarker testing when it is supported by medical and scientific evidence. The bills are designed to ensure patients can access precision medicine by aligning coverage with FDA-approved tests and nationally recognized clinical guidelines. Overall, the legislation aims to reduce barriers to timely, personalized treatment—particularly in cancer care.

How Can YOU Help?

You have a powerful voice.  Reaching out to lawmakers is a critical step in protecting vital services for patients. Please contact your state lawmakers and urge them to support and advance the legislation.   Personalized messages make a difference!